Biostem Technologies Inc's Competitiveness
A competitive positioning analysis and financial ratio benchmarking of Biostem Technologies Inc (BSEM) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.
Key Findings: Biostem Technologies Inc vs Its Competitors
- Peer revenue share: Biostem Technologies Inc accounted for 100.0% of combined revenue among its tracked peer group, up from 100.0% a year earlier.
Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).
BSEM Sales vs. its Competitors, Q2 2026
Biostem Technologies Inc generated 100.00 % of the combined sales of its peer group, up from 100.00 % a year earlier.
API endpoints for this dataset
For context: the Biotechnology & Pharmaceuticals industry grew revenue 21.4% year over year, combined, vs -28.0% for Biostem Technologies Inc. Biostem Technologies Inc's share of combined industry revenue moved from 0.03% to 0.02%, a loss of 0.01 percentage points.